Registration is now open for the Spring 2024 IAS-USA Annual Update on HIV Management in Atlanta, Georgia

This live course will be in person at the Cobb Galleria Centre. There will NOT be a simultaneous virtual component for this course, but the on-demand activity will be available a week following the course.

This in-person course will focus on recent advances in HIV medicine, including updates from Conference on Retroviruses and Opportunistic Infections (CROI) 2024, new antiretroviral formulations and strategies, new approaches to HIV cure, management of substance use disorder (SUD) in people with HIV, sexually transmitted infections (STIs), overview of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) study, immunizations in adults with HIV, and will feature a case-based panel discussion on antiretroviral therapy.

For more information and to register, visit the activity page: https://www.iasusa.org/events/hiv-update-2024-atlanta/

Continuing Education Credits

The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The IAS–USA designates this enduring material for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.